Amir Reichman
Chief Executive Officer bij SCINAI IMMUNOTHERAPEUTICS LTD.
Vermogen: - $ op 31-03-2024
Profiel
Amir Reichman is the founder of NeuroDerm Ltd.
which was founded in 2003.
He was the Chief Engineer & Senior Scientist from 2003 to 2009.
Currently, he is the Chief Executive Officer & Director at Scinai Immunotherapeutics Ltd.
since 2021.
Previously, he worked at GlaxoSmithKline Pharmaceuticals SA (Belgium) as the Head-Global Vaccines Engineering Core Technology from 2015 to 2021 and at Novartis Vaccines & Diagnostics, Inc. (North Carolina) as the Head-Global Vaccines Value Chain Management from 2011 to 2015.
Mr. Reichman completed his undergraduate degree from Ben-Gurion University of the Negev and his MBA from The Wharton School of the University of Pennsylvania.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 15-03-2023 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Amir Reichman
| Bedrijven | Functie | Begin |
|---|---|---|
| SCINAI IMMUNOTHERAPEUTICS LTD. | Chief Executive Officer | 02-03-2021 |
Eerdere bekende functies van Amir Reichman
| Bedrijven | Functie | Einde |
|---|---|---|
GlaxoSmithKline Pharmaceuticals SA (Belgium)
 GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology GlaxoSmithKline Pharmaceuticals SA develops and manufactures pharmaceuticals and vaccines. The company is headquartered in Wavre, Belgium. | Corporate Officer/Principal | 01-03-2021 |
| Novartis Vaccines & Diagnostics, Inc. (North Carolina) | Corporate Officer/Principal | 01-01-2015 |
| NEURODERM LTD | Founder | 01-01-2009 |
Opleiding van Amir Reichman
| Ben-Gurion University of the Negev | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SCINAI IMMUNOTHERAPEUTICS LTD. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
NeuroDerm Ltd.
 NeuroDerm Ltd. BiotechnologyHealth Technology NeuroDerm Ltd. operates as a clinical-stage pharmaceutical company. It engages in the development of next-generation treatments for central nervous system disorders. The company was founded by Eliahu Heldman on March 18, 2003 and is headquartered in Rehovot, Israel. | Health Technology |
GlaxoSmithKline Pharmaceuticals SA (Belgium)
GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology GlaxoSmithKline Pharmaceuticals SA develops and manufactures pharmaceuticals and vaccines. The company is headquartered in Wavre, Belgium. | Health Technology |
| Novartis Vaccines & Diagnostics, Inc. (North Carolina) |
